Literature DB >> 1535100

The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients.

J Bauer1, L Wildt, D Flügel, H Stefan.   

Abstract

Ten female patients suffering from catamenial epilepsy were treated with a synthetic analogue of the gonadotrophin releasing hormone (GnRH) in addition to antiepileptic drugs. Three of the patients became seizure free, in four patients seizure frequency decreased and in one patient seizures were of shorter duration. In only two of the patients was there no therapeutic effect. Adverse effects, including hot flushes, headache and increase in weight, were noticed in eight patients. These results support the hypothesis that treatment with a synthetic GnRH analogue might be helpful in patients with intractable catamenial epilepsies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535100     DOI: 10.1007/bf00810354

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  LH-releasing activity of potent LH-RH analogs in vitro.

Authors:  D H Coy; F Labrie; M Savary; E J Coy; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1975-11-17       Impact factor: 3.575

2.  Epilepsy and menstruation; the role of water retention.

Authors:  B ANSELL; E CLARKE
Journal:  Lancet       Date:  1956-12-15       Impact factor: 79.321

3.  Phenytoin pharmacokinetics in catamenial epilepsy.

Authors:  G Shavit; P Lerman; A D Korczyn; S Kivity; M Bechar; S Gitter
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

4.  Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders.

Authors:  A G Herzog
Journal:  Neurology       Date:  1986-12       Impact factor: 9.910

5.  Timing of seizure recurrence in adult epileptic patients: a statistical analysis.

Authors:  J G Milton; J Gotman; G M Remillard; F Andermann
Journal:  Epilepsia       Date:  1987 Sep-Oct       Impact factor: 5.864

6.  The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women.

Authors:  J J Jacono; J M Robertson
Journal:  Epilepsia       Date:  1987 Sep-Oct       Impact factor: 5.864

7.  Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy.

Authors:  D Rościszewska; B Buntner; I Guz; L Zawisza
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

8.  Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma.

Authors:  S Waibel-Treber; H W Minne; S H Scharla; T Bremen; R Ziegler; G Leyendecker
Journal:  Hum Reprod       Date:  1989-05       Impact factor: 6.918

Review 9.  Catamenial epilepsy: a review.

Authors:  M E Newmark; J K Penry
Journal:  Epilepsia       Date:  1980-06       Impact factor: 5.864

10.  Intermittent clobazam for catamenial epilepsy: tolerance avoided.

Authors:  M Feely; J Gibson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-12       Impact factor: 10.154

View more
  15 in total

1.  Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial.

Authors:  A G Herzog; K M Fowler; S D Smithson; L A Kalayjian; C N Heck; M R Sperling; J D Liporace; C L Harden; B A Dworetzky; P B Pennell; J M Massaro
Journal:  Neurology       Date:  2012-05-30       Impact factor: 9.910

Review 2.  Effects of the Menstrual Cycle on Neurological Disorders.

Authors:  Hannah J Roeder; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

Review 3.  Treatments for seizures in catamenial (menstrual-related) epilepsy.

Authors:  Melissa J Maguire; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2019-10-14

Review 4.  Hormonal therapy for epilepsy.

Authors:  Scott J Stevens; Cynthia L Harden
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 5.  The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment.

Authors:  Constance Guille; Susan Spencer; Idil Cavus; C Neill Epperson
Journal:  Epilepsy Behav       Date:  2008-03-17       Impact factor: 2.937

Review 6.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

Review 7.  A Treatment Approach to Catamenial Epilepsy.

Authors:  Allison Navis; Cynthia Harden
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

8.  Hormonal therapies: progesterone.

Authors:  Andrew G Herzog
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 9.  Neuroendocrine aspects of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Horm Behav       Date:  2012-05-02       Impact factor: 3.587

Review 10.  Managing Epilepsy in Women.

Authors:  Elizabeth E Gerard; Kimford J Meador
Journal:  Continuum (Minneap Minn)       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.